Key EventTrading window closure announced ahead of quarterly results
Supriya Lifescience Ltd (SUPRIYA)
·Next Day Close·-0.01%·₹984.8
Key EventAll five resolutions passed with requisite majority at the 18th AGM.
ImpactShareholders approved all key governance and financial items with near-unanimous support, signaling strong governance confidence.Sign up to read impact
Supriya Lifescience Ltd (SUPRIYA)
·Next Day Close·-3.83%·₹962.45
Key EventCourt permits provisional release of ketamine shipment
ImpactShareholders should monitor further court developments and potential additional compliance costs.Sign up to read impact
Supriya Lifescience Ltd (SUPRIYA)
·Next Day Close·+5.79%·₹957.95
Key EventCompany schedules virtual analyst meeting for September 25, 2026.
ImpactInvestors can directly engage with management during the scheduled virtual session.Sign up to read impact
Supriya Lifescience Ltd (SUPRIYA)
·Next Day Close·-3.23%·₹874.7
Key EventCompany schedules virtual analyst/investor meeting for September 17, 2026.
ImpactShareholders can attend the virtual meeting to hear management updates and access the investor presentation online.Sign up to read impact
Supriya Lifescience Ltd (SUPRIYA)
·Next Day Close·+0.13%·₹842.6
Key EventAGM scheduled for September 24, 2026 via video conference
ImpactShareholders can access the report online and must register emails for future communications.Sign up to read impact
Supriya Lifescience Ltd (SUPRIYA)
·Next Day Close·+0.13%·₹842.6
Key EventLegal case involving GM remains unresolved
ImpactThe unresolved legal matter poses no immediate financial impact but requires ongoing monitoring for potential future developments affecting the company.Sign up to read impact
Supriya Lifescience Ltd (SUPRIYA)
·Next Day Close·+4.87%·₹841.5
Key EventFY25-26 revenue reached ₹828 crore with EBITDA margin of 36.85% and ROCE of 22.38%, marking highest-ever financial performance.
ImpactThe company delivered record financial performance with strong growth in key therapeutic segments and strategic expansion plans, positioning it for sustained long-term value creation.Sign up to read impact
Supriya Lifescience Ltd (SUPRIYA)
·Next Day Close·+4.87%·₹841.5
Key EventAGM scheduled for September 24, 2026, with dividend approval and auditor remuneration vote
ImpactShareholders receive ₹1 per share dividend if holding shares by September 4, 2026, with tax implications depending on residency status.Sign up to read impact
Supriya Lifescience Ltd (SUPRIYA)
·Next Day Close·+4.87%·₹841.5
Key Event18th Annual General Meeting scheduled for September 24, 2026, with AGM notice and BRSR filed electronically.
ImpactThe BRSR filing confirms Supriya Lifescience's commitment to ESG compliance and transparency, with no material risks or financial updates disclosed.Sign up to read impact